NewsSource: EClinCloud official website historical archive

EClinCloud Invites You to the 2025 DIA China Annual Meeting to Explore the Transformative Potential of AI in Clinical Research

1 min readEClinCloud Editorial Team
Cover image for archived article: EClinCloud invites you to join us at the 2025 DIA China Annual Meeting to explore the transformative potential of AI in clinical research

From May 22 to 25, EClinCloud will appear at the 2025 DIA China Annual Meeting & Exhibition.

The conference brings together pharmaceutical leaders and experts from more than 30 countries and regions worldwide to discuss cutting-edge topics in pharmaceutical innovation and regulation.

At this event, EClinCloud will showcase its AI-driven digital clinical research solutions on-site, and our consulting team will be at the booth to meet with you in person and answer your questions. We welcome you to visit us to discuss industry trends and explore a new future for clinical research together.

 

一临云2025 DIA大会Q20展位海报  

 

 

Expert Discussions

2025 DIA风险管理圆桌讨论议程  

 

Booth Interactions

Visit the EClinCloud booth to discuss:

AI-driven innovation in clinical R&D

International-standard technology and practical experience

Medical expertise integrated with innovative applications of AI technology

……

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.